지식경영연구 (Knowledge Management Research)

한국지식경영학회 (The Knowledge Management Society of Korea)
권호 표지
DOI QR코드

DOI QR Code

Influence of R&D intensity on Innovation Performance in the Korean Pharmaceutical Industry: Focusing on the Moderating Effects of R&D Collaboration

  • 투고 : 2018.06.30
  • 심사 : 2018.08.13
  • 발행 : 2018.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This paper examined the effect of innovation networks comprising research and development (R&D) collaboration on innovation performance of Korean pharmaceutical firms. As co-assigned patents and co-affiliated publications are common technical outcomes of successful R&D collaboration in the pharmaceutical industry, social network analysis technique was applied for analyzing innovation networks through patent and publication data. Results of Social network analysis indicated that a small set of highly innovative firms in the Korean pharmaceutical industry were actively involved in patenting and publishing. And the analysis of structural equation model found the followings: (1) R&D intensity significantly affected patenting, publication and new drug development, (2) the activity of patenting and publishing was positively related with the innovation performance measured by new drug development, and (3) R&D collaboration in terms of degree centrality of co-patent network played significant moderating roles on the relationships among R&D intensity, patenting, and new drug development. These findings are expected to be helpful to researchers as well as policy-makers to devise innovation-promoting policies in the Korean pharmaceutical industry. Discussions and limitations of the study are provided in the last part.

키워드

참고문헌

  1. Ahuja, G. 2000. "Collaboration networks, structural holes, and innovation: A longitudinal study," Administrative Science Quarterly (45:3), pp. 425-455. https://doi.org/10.2307/2667105
  2. Austin, D. H. 1993. "An event-study approach to measuring innovative output: The case of biotechnology," The American Economic Review (83:2), pp. 253-258.
  3. Baregheh, A., Rowley, J. and Sambrook, S. 2009. "Towards a multidisciplinary definition of innovation," Management Decision (47), pp. 1323-1339. https://doi.org/10.1108/00251740910984578
  4. Barney, J. 1991. "Firm resources and sustained competitive advantage," Journal of management (17:1), pp. 99-120. https://doi.org/10.1177/014920639101700108
  5. Belleflamme, P. and Peitz, M. 2015. Industrial organization: markets and strategies, New York: Cambridge University Press.
  6. Bommer, M. and Jalajas, D. S. 2004. "Innovation sources of large and small technology-based firms," IEEE Transactions on Engineering Management (51:1), pp. 13-18.
  7. Bonacich, P. 1972. "Factoring and weighting approaches to status scores and clique identification," Journal of Mathematical Sociology (2), pp. 113-120. https://doi.org/10.1080/0022250X.1972.9989806
  8. Bonacich, P. 2007. "Some unique properties of eigenvector centrality," Social Networks (29), pp. 555-564. https://doi.org/10.1016/j.socnet.2007.04.002
  9. Borgatti, S. P. and Cross, R. 2003. "A relational view of information seeking and learning in social networks," Management Science (49:4), pp. 432-445. https://doi.org/10.1287/mnsc.49.4.432.14428
  10. Breschi, S. and Catalini, C. 2010. "Tracing the links between science and technology: An exploratory analysis of scientists' and inventors' networks," Research Policy (39:1), pp. 14-26. https://doi.org/10.1016/j.respol.2009.11.004
  11. Burt, R. S. 1995. Structural Holes: The Social Structure of Competition. Cambridge, Massachusetts: Harvard University Press.
  12. Cantner, U., Meder, A. and TerWal, A. L. 2010. "Innovator networks and regional knowledge base," Technovation (30:9), pp. 496-507. https://doi.org/10.1016/j.technovation.2010.04.002
  13. Chan, K. C., Chen, C. R. and Cheng, L. T. 2005. "Ranking research productivity in accounting for Asia-Pacific universities," Review of Quantitative Finance and Accounting (24:1), pp. 47-64. https://doi.org/10.1007/s11156-005-5326-5
  14. Chesbrough, H. 2006. Open innovation: The new imperative for creating and profiting from technology, Boston, Massachusetts: Harvard Business School Publishing.
  15. Cockburn, I. M. and Henderson, R. M. 1998. "Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery," The Journal of Industrial Economics (46:2), pp. 157-182. https://doi.org/10.1111/1467-6451.00067
  16. Cohen, W. M. and Klepper, S. 1996. "Firm Size and the Nature of Innovation within Industries: The Case of Process and Product R&D," Review of Economics and Statistics (78), pp. 232-243. https://doi.org/10.2307/2109925
  17. Cohen, W. M. and Levin, R. C. 1989. "Empirical studies of innovation and market structure," in Handbook of Industrial Organization (Volume 2), R. Schmalensee and R. Willig (eds.), North Holland: Elsevier, pp. 1059-1107.
  18. Cohen, W. M., Levin, R. C. and Mowery, D. C. 1987. Firm size and R&D intensity: A re-examination, Cambridge, Mass., USA: National Bureau of Economic Research.
  19. Comanor, W. S. 1964. "Research and competitive product differentiation in the pharmaceutical industry in the United States" Economica (31:124), pp. 372-384. https://doi.org/10.2307/2550516
  20. Comanor, W. S. and Scherer, F. M. 1969. "Patent statistics as a measure of technical change," The Journal of Political Economy (77:3), pp. 392-398. https://doi.org/10.1086/259522
  21. Cooper, J. R. 1998. "A multidimensional approach to the adoption of innovation," Management decision (36:8), pp. 493-502. https://doi.org/10.1108/00251749810232565
  22. Crane, D. 1969. "Social structure in a group of scientists: A test of the" invisible college" hypothesis," American Sociological Review (34:3), pp. 335-352. https://doi.org/10.2307/2092499
  23. Cross, R. and Cummings, J. N. 2004. "Tie and network correlates of individual performance in knowledge-intensive work," Academy of Management Journal (47:6), pp. 928-937. https://doi.org/10.2307/20159632
  24. Drucker, P. 2002. "The discipline of innovation," Harvard Business Review (Aug), pp. 5-10.
  25. Dyer, J. H. and Singh, H. 1998. "The relational view: Cooperative strategy and sources of interorganizational competitive advantage," Academy of management review (23:4), pp. 660-679. https://doi.org/10.5465/amr.1998.1255632
  26. Echols, A. and Tsai, W. 2005. "Niche and Performance: The Moderating Role of Network Embeddedness," Strategic management journal (26:3), pp. 219-238. https://doi.org/10.1002/smj.443
  27. Fleming, L., King, C. and Juda, A. I. 2007. "Small worlds and regional innovation," Organization Science (18:6), pp. 938-954. https://doi.org/10.1287/orsc.1070.0289
  28. Freeman, L. C. 1979. "Centrality in social networks conceptual clarification," Social networks (1:3), pp. 215-239. https://doi.org/10.1016/0378-8733(78)90021-7
  29. Galambos, L. and Sturchio, J. L. 1998. "Pharmaceutical firms and the transition to biotechnology: A study in strategic innovation," Business History Review (72:2), pp. 250-278. https://doi.org/10.2307/3116278
  30. Garfield, E. and Welljams-Dorof, A. 1992. "Citation data: Their use as quantitative indicators for science and technology evaluation and policy-making," Science and Public Policy (19:5), pp. 321-327.
  31. Gay, B. and Dousset, B. 2005. "Innovation and network structural dynamics: Study of the alliance network of a major sector of the biotechnology industry," Research Policy (34:10), pp. 1457-1475. https://doi.org/10.1016/j.respol.2005.07.001
  32. Godin, B. 1996. "Research and the practice of publication in industries," Research policy (25:4), pp. 587-606. https://doi.org/10.1016/0048-7333(95)00859-4
  33. Goetze, C. 2010. "An empirical enquiry into co-patent networks and their stars: The case of cardiac pacemaker technology," Technovation (30), pp. 436-446. https://doi.org/10.1016/j.technovation.2010.03.003
  34. Gorraiz, J., Reimann, R. and Gumpenberger, C. 2012. "Key factors and considerations in the assessment of international collaboration: a case study for Austria and six countries," Scientometrics (91:2), pp. 417-433. https://doi.org/10.1007/s11192-011-0579-3
  35. Grabowski, H. 2002. "Patents, innovation and access to new pharmaceuticals," Journal of International Economic Law (5:4), pp. 849-860. https://doi.org/10.1093/jiel/5.4.849
  36. Granovetter, M. S. 1973. "The strength of weak ties," American journal of sociology (78:6), pp. 1360-1380. https://doi.org/10.1086/225469
  37. Grant, R. M. 1996. "Toward a knowledge-based theory of the firm," Strategic Management Journal (17), pp. 109-122.
  38. Griliches, Z. 1994. "Productivity, R&D, and the data constraint," The American Economic Review (84:1), pp. 1-23.
  39. Hall, B. H., Griliches, Z. and Hausman, J. A. 1984. Patents and R&D: Is There A Lag?, Cambridge, Mass., USA.: National Bureau of Economic Research.
  40. Haynie, D. L. 2001. "Delinquent peers revisited: Does network structure matter?" American journal of sociology (106:4), pp. 1013-1057. https://doi.org/10.1086/320298
  41. Henderson, R . and Cockburn, I. 1994. "Measuring competence?: Exploring firm effects in pharmaceutical research," Strategic management journal (15:S1), pp. 63-84.
  42. Hooper, D., Coughlan, J. and Mullen, M. 2008. "Structural equation modelling: Guidelines for determining model fit," Electronic Journal of Business Research Methods (6:1), pp. 53-60.
  43. Hughes, K. 1988. "The interpretation and measurement of R&D intensity-A note," Research Policy (17:5), pp. 301-307. https://doi.org/10.1016/0048-7333(88)90010-8
  44. Jong, S. and Slavova, K. 2014. "When publications lead to products: The open science conundrum in new product development," Research Policy (43), pp. 645-654. https://doi.org/10.1016/j.respol.2013.12.009
  45. Juliano, R. 2013. "Pharmaceutical innovation and public policy: The case for a new strategy for drug discovery and development," Science and Public Policy (40:3), pp. 393-405. https://doi.org/10.1093/scipol/scs125
  46. Kim, C. and Park, J. H. 2010. "The global research-and-development network and its effect on innovation," Journal of International Marketing (18:4), pp. 43-57. https://doi.org/10.1509/jimk.18.4.43
  47. Kim, Y. 2002. "Executive social capital and its impacts on job promotion," Academy of Management Proceedings: 2002 (Meeting Abstract Supplement) J1-J6.
  48. Ko, Y. H. and Lee, M. H. 2013. "A Study on Properties of Patents in the Applicants and Possibility of Economical Usage-Focused on Pharmaceutical Chemistry Industry Sector," Knowledge Management Research (14:1), pp. 39-54.
  49. Lee, M. and Choi, M. 2015. "Analysis on Time-Lag Effect of Research and Development Investment in the Pharmaceutical Industry in Korea," Osong Public Health and Research Perspectives (6), pp. 241-248. https://doi.org/10.1016/j.phrp.2015.07.001
  50. Levin, R. C., Klevorick, A. K., Nelson, R. R., Winter, S. G., Gilbert, R. and Griliches, Z. 1987. "Appropriating the returns from industrial research and development," Brookings papers on economic activity (1987:3), pp. 783-831. https://doi.org/10.2307/2534454
  51. Mazzola, E., Perrone, G. and Kamuriwo, D. S. 2015. "Network embeddedness and new product development in the biopharmaceutical industry: The moderating role of open innovation flow," International Journal of Production Economics (160), pp. 106-119. https://doi.org/10.1016/j.ijpe.2014.10.002
  52. McKelvey, M. and Rake, B. 2012. "Research Network Position and Innovative Performance: Evidence from the Pharmaceutical Industry," Jena Economic Research Papers (2012-021), pp. 1-34.
  53. Melin, G. and Persson, O. 1996. "Studying research collaboration using co-authorships," Scientometrics (36:3), pp. 363-377. https://doi.org/10.1007/BF02129600
  54. Merton, R. K. 1968. "The Matthew effect in science," Science (159:3810), pp. 56-63. https://doi.org/10.1126/science.159.3810.56
  55. Merton, R. K. 1988. "The Matthew effect in science, II: Cumulative advantage and the symbolism of intellectual property," Isis (79:4), pp. 606-623. https://doi.org/10.1086/354848
  56. Narin, F., Noma, E. and Perry, R. 1987. "Patents as indicators of corporate technological strength," Research policy (16:2-4), pp. 143-155. https://doi.org/10.1016/0048-7333(87)90028-X
  57. Newman, M. E. 2004. "Coauthorship networks and patterns of scientific collaboration," Proceedings of the National Academy of Sciences of the United States of America (101:Suppl 1), pp. 5200-5205. https://doi.org/10.1073/pnas.0307545100
  58. Newman, M. E. 2001. "The structure of scientific collaboration networks," Proceedings of the National Academy of Sciences (98:2), pp. 404-409. https://doi.org/10.1073/pnas.98.2.404
  59. Nunes, P. M., Serrasqueiro, Z. and Leitao, J. 2012. "Is there a linear relationship between R&D intensity and growth? Empirical evidence of non-high-tech vs. high-tech SMEs," Research policy (41:1), pp. 36-53. https://doi.org/10.1016/j.respol.2011.08.011
  60. OECD. 2005. The measurement of scientific and technological activities. Proposed Guidelines for Collecting and Interpreting Technological Innovation Data, European Commission and Eurostat.
  61. Oehme, M. and Bort, S. 2015. "SME internationalization modes in the German biotechnology industry: The influence of imitation, network position, and international experience," Journal of International Business Studies (46:6), pp. 629-655. https://doi.org/10.1057/jibs.2015.8
  62. Owen-Smith, J., Riccaboni, M., Pammolli, F. and Powell, W. W. 2002. "A Comparison of U. S. and European University-Industry Relations in the Life Sciences," Management Science (48:1), pp. 24-43. https://doi.org/10.1287/mnsc.48.1.24.14275
  63. Pakes, A. and Griliches, Z. 1980. "Patents and R&D at the firm level: A first report," Economics Letters (5:4), pp. 377-381. https://doi.org/10.1016/0165-1765(80)90136-6
  64. Pakes, A., Simpson, M., Judd, K. and Mansfield, E. 1989. "Patent renewal data. Brookings papers on economic activity," Microeconomics, pp. 331-410.
  65. Park, K. H. and Choo, K. 2010. "A Study on the Determinants of the Economic Value of Patents Using Renewal Data," Knowledge Management Research (11:1), pp. 65-80.
  66. Pavitt, K. 1991. "What makes basic research economically useful?" Research policy (20:2), pp. 109-119. https://doi.org/10.1016/0048-7333(91)90074-Z
  67. Penrose, E. T. 1995. The Theory of the Growth of the Firm, New York: Oxford University Press.
  68. Pisano, G. P. 2006. Science business: The promise, the reality, and the future of biotech, Boston, Massachusetts: Harvard Business Press.
  69. Porter, M. E. 1998. Competitive advantage: Creating and sustaining superior performance, Free press.
  70. Powell, W. W. 1996. "Inter-organizational collaboration in the biotechnology industry," Journal of Institutional and Theoretical Economics (JITE)/Zeitschrift fur die gesamte Staatswissenschaft (151:1), pp. 197-215.
  71. Powell, W. W., Koput, K. W. and Smith-Doerr, L. 1996. "Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology," Administrative science quarterly (41:1), pp. 116-145. https://doi.org/10.2307/2393988
  72. Powell, W. W., Koput, K. W., Smith-Doerr, L. and Owen-Smith, J. 1999. "Network position and firm performance: Organizational returns to collaboration in the biotechnology industry," Research in the Sociology of Organizations (16:1), pp. 129-159.
  73. Rampersad, G., Quester, P. and Troshani, I. 2010. "Managing innovation networks: Exploratory evidence from ICT, biotechnology and nanotechnology networks," Industrial Marketing Management (39:5), pp. 793-805. https://doi.org/10.1016/j.indmarman.2009.07.002
  74. Rogers, M. 1998. The Definition and Measurement of Innovation (No. 10/98), Melbourne Institute of Applied Economic and Social Research.
  75. Rosenberg, N. 1990. "Why do firms do basic research (with their own money)?" Research policy (19:2), pp. 165-174. https://doi.org/10.1016/0048-7333(90)90046-9
  76. Salter, A. and Gann, D. 2003. "Sources of ideas for innovation in engineering design," Research policy (32:8), pp. 1309-1324. https://doi.org/10.1016/S0048-7333(02)00119-1
  77. Scherer, F. M. 1965. "Firm size, market structure, opportunity, and the output of patented inventions," The American Economic Review (55:5), pp. 1097-1125.
  78. Scherer, F. M. 2010. "Pharmaceutical innovation," in Handbook of the Economics of Innovation (1), B. H. Hall and N. Rosenberg (eds.), North Holland: Elsevier, pp. 539-574.
  79. Schermelleh-Engel, K. 2003. "Evaluating the fit of structural equation models: Tests of significance and descriptive goodness-of-fit measures," Methods of Psychological Research Online (8:2), pp. 23-74.
  80. Schmookler, J. and Brownlee, O. 1962. "Determinants of inventive activity," The American Economic Review (52:2), pp. 165-176.
  81. Schmookler, J. 1966. Invention and economic growth, Cambridge, Massachusetts.: Harvard University Press.
  82. Schumacker, R. and Lomax, R. 2010. A beginner's guide to structural equation modeling (3rd ed.), Routledge.
  83. Schumpeter, J. 1942. Capitalism, socialism and democracy. New York, NY: HarperCollins.
  84. Schumpeter, J. A. 1934 (2012). The Theory of Economic Development: An Inquiry Into Profits, Capital, Credit, Interest, and the Business Cycle, translated from the German by Redvers Opie, New Brunswick (U.S.A) and London (U.K.): Transaction Publishers.
  85. Scott, J. 2010. Social network analysis, London, U.K: SAGE Publications Ltd.
  86. Singh, J. 2005. "Collaborative networks as determinants of knowledge diffusion patterns," Management Science (51:5), pp. 756-770. https://doi.org/10.1287/mnsc.1040.0349
  87. Soh, P. H. and Roberts, E. B. 2003. "Networks of innovators: a longitudinal perspective," Research policy (32:9), pp. 1569-1588. https://doi.org/10.1016/S0048-7333(03)00065-9
  88. Sohn, D., Hur, W. and Kim, H. 2010. "Effects of R&D and patents on the financial performance of Korean venture firms," Asian Journal of Technology Innovation (18:2), pp. 169-185. https://doi.org/10.1080/19761597.2010.9668697
  89. Sternitzke, C. 2010. "Knowledge sources, patent protection, and commercialization of pharmaceutical innovations," Research policy (39:6), pp. 810-821. https://doi.org/10.1016/j.respol.2010.03.001
  90. Stuart, T. E., Ozdemir, S. Z. and Ding, W. W. 2007. "Vertical alliance networks: The case of university-biotechnology-pharmaceutical alliance chains," Research Policy (36:4), pp. 477-498. https://doi.org/10.1016/j.respol.2007.02.016
  91. Sykes, R. 1998. "Being a modern pharmaceutical company involves making information available on clinical trial programmes," British Medical Journal (317:7167), pp. 1172-1180. https://doi.org/10.1136/bmj.317.7167.1172
  92. Teece, D. J. 1986. "Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy," Research Policy (15:6), pp. 285-305. https://doi.org/10.1016/0048-7333(86)90027-2
  93. Trajtenberg, M. 1990. "A penny for your quotes: patent citations and the value of innovations," The RAND Journal of Economics (21:1), pp. 172-187. https://doi.org/10.2307/2555502
  94. Tsai, W. 2001. "Knowledge transfer in intraorganizational networks: Effects of network position and absorptive capacity on business unit innovation and performance," Academy of Management Journal (44:5), pp. 996-1004. https://doi.org/10.2307/3069443
  95. Uddin, S., Hossain, L. and Rasmussen, K. 2013. "Network Effects on Scientific Collaborations," PLoS ONE (8:2), e57546. https://doi.org/10.1371/journal.pone.0057546
  96. Van Looy, B., Callaert, J. and Debackere, K. 2006. "Publication and patent behavior of academic researchers: Conflicting, reinforcing or merely co-existing?" Research policy (35:4), pp. 596-608. https://doi.org/10.1016/j.respol.2006.02.003
  97. Uzzi, B. 1996. "The sources and consequences of embeddedness for the economic performance of organizations: The network effect," American Sociological Review (61:4), pp. 674-698. https://doi.org/10.2307/2096399
  98. Wager, E., Field, E. A. and Grossman, L. 2003. "Good publication practice for pharmaceutical companies," Current Medical Research and Opinion (19:3), pp. 149-154. https://doi.org/10.1185/030079903125001767
  99. Walker, G., Kogut, B. and Shan, W. 1997. "Social capital, structural holes and the formation of an industry network," Organization Science (8:2), pp. 109-125. https://doi.org/10.1287/orsc.8.2.109
  100. Wang, J. and Guan, J. 2005. "The analysis and evaluation of knowledge efficiency in research groups," Journal of the American Society for Information Science and Technology (56:11), pp. 1217-1226. https://doi.org/10.1002/asi.20225
  101. Wang, N. and Hagedoorn, J. 2014. "The lag structure of the relationship between patenting and internal R&D revisited," Research Policy (43:8), pp. 1275-1285. https://doi.org/10.1016/j.respol.2014.03.010
  102. Wasserman, S. and Faust, K. 1994 (2009). Social network analysis: Methods and applications, New York, NY: Cambridge university press.
  103. Williamson, O. E. 1979. "Transaction-cost economics: the governance of contractual relations," Journal of law and economics (22:2), pp. 233-261. https://doi.org/10.1086/466942
  104. Williamson, O. E. 1989. "Transaction cost economics," Handbook of industrial organization (1), pp. 135-182.
  105. Wright, S. 1934. " The method of path coefficients," The Annals of Mathematical Statistics (5:3), pp. 161-215. https://doi.org/10.1214/aoms/1177732676
  106. Zaheer, A. and Bell, G. G. 2005. "Benefiting from network position: firm capabilities, structural holes, and performance," Strategic Management Journal (26:9), pp. 809-825. https://doi.org/10.1002/smj.482
  107. Zeng, S. X., Xie, X. M., and Tam, C. M. 2010. "Relationship between cooperation networks and innovation performance of SMEs," Technovation (30:3), pp. 181-194. https://doi.org/10.1016/j.technovation.2009.08.003

피인용 문헌

  1. Platform Business and Value Creation: Using Public Open Data vol.20, pp.1, 2019, https://doi.org/10.15813/kmr.2019.20.1.007